Pillar Pacific Capital Management’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-14,000
Closed -$78K 299
2017
Q3
$78K Hold
14,000
0.01% 291
2017
Q2
$65K Hold
14,000
0.01% 297
2017
Q1
$69K Hold
14,000
0.01% 297
2016
Q4
$155K Hold
14,000
0.02% 295
2016
Q3
$129K Hold
14,000
0.02% 293
2016
Q2
$89K Hold
14,000
0.02% 294
2016
Q1
$91K Hold
14,000
0.02% 291
2015
Q4
$114K Hold
14,000
0.02% 282
2015
Q3
$103K Hold
14,000
0.02% 282
2015
Q2
$144K Hold
14,000
0.02% 279
2015
Q1
$129K Buy
+14,000
New +$125K 0.02% 281

Other funds holding FOMX

Pillar Pacific Capital Management's FOMX Position: Q4 2017 in Review

Pillar Pacific Capital Management sold out of Foamix Pharmaceuticals Ltd. Ordinary Shares (FOMX) in Q4 2017, closing a stake of 14,000 shares — an estimated $78K sold.

Pillar Pacific Capital Management first reported a position in FOMX in Q1 2015 and held it in 11 quarters. The position peaked at $155K in Q4 2016. 48 funds tracked by Wall St. Rank hold FOMX as of Q4 2017.

  • Pillar Pacific Capital Management reported no remaining Foamix Pharmaceuticals Ltd. Ordinary Shares position as of Q4 2017 after selling out during the quarter.
  • Pillar Pacific Capital Management sold 14,000 Foamix Pharmaceuticals Ltd. Ordinary Shares shares in Q4 2017, an estimated $78K.
  • Pillar Pacific Capital Management first reported a position in Foamix Pharmaceuticals Ltd. Ordinary Shares in Q1 2015 and held it in 11 quarters.
  • Pillar Pacific Capital Management's Foamix Pharmaceuticals Ltd. Ordinary Shares position peaked at $155K in Q4 2016.
  • 48 funds tracked by Wall St. Rank held Foamix Pharmaceuticals Ltd. Ordinary Shares as of Q4 2017.

Based on Pillar Pacific Capital Management's 13F filing for Q4 2017, filed 26 Jan 2018.